Evaxion Biotech A/S
NASDAQ:EVAX
Evaxion Biotech A/S
NASDAQ:EVAX
Price:
3.34
USD
4.7%
Market Closed
Market Cap:
$21.1m
Balance Sheet
Balance Sheet Decomposition
Evaxion Biotech A/S
Evaxion Biotech A/S
Balance Sheet Decomposition is not available for
Evaxion Biotech A/S
Evaxion Biotech A/S
Balance Sheet
Evaxion Biotech A/S
Evaxion Biotech A/S
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
7
|
10
|
6
|
32
|
13
|
6
|
6
|
|
| Cash |
7
|
10
|
6
|
32
|
13
|
6
|
6
|
|
| Total Receivables |
1
|
1
|
2
|
1
|
1
|
1
|
2
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
1
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
3
|
1
|
3
|
2
|
1
|
|
| Total Current Assets |
8
|
11
|
11
|
35
|
17
|
8
|
9
|
|
| PP&E Net |
0
|
0
|
0
|
5
|
5
|
4
|
4
|
|
| PP&E Gross |
0
|
0
|
0
|
5
|
5
|
4
|
4
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
2
|
2
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Assets |
9
N/A
|
11
+30%
|
12
+8%
|
40
+236%
|
22
-45%
|
13
-41%
|
12
-3%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
1
|
3
|
3
|
2
|
3
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
9
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
1
|
1
|
2
|
1
|
1
|
4
|
1
|
|
| Total Current Liabilities |
9
|
2
|
5
|
4
|
4
|
7
|
4
|
|
| Long-Term Debt |
0
|
0
|
0
|
3
|
10
|
10
|
10
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
9
N/A
|
2
-82%
|
5
+186%
|
8
+57%
|
14
+78%
|
18
+28%
|
14
-20%
|
|
| Equity | ||||||||
| Common Stock |
2
|
2
|
3
|
4
|
4
|
6
|
11
|
|
| Retained Earnings |
3
|
7
|
4
|
29
|
4
|
11
|
12
|
|
| Total Equity |
1
N/A
|
9
N/A
|
7
-25%
|
32
+361%
|
8
-74%
|
5
N/A
|
2
+65%
|
|
| Total Liabilities & Equity |
9
N/A
|
11
+30%
|
12
+8%
|
40
+236%
|
22
-45%
|
13
-41%
|
12
-3%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
19
|
0
|
19
|
23
|
24
|
38
|
70
|
|
Switch to:
Switch to:
See Also
Discover More
